E Larsson

1.2k total citations
45 papers, 1000 citations indexed

About

E Larsson is a scholar working on Surgery, Rheumatology and Transplantation. According to data from OpenAlex, E Larsson has authored 45 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 13 papers in Rheumatology and 10 papers in Transplantation. Recurrent topics in E Larsson's work include Renal Transplantation Outcomes and Treatments (10 papers), Transplantation: Methods and Outcomes (9 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). E Larsson is often cited by papers focused on Renal Transplantation Outcomes and Treatments (10 papers), Transplantation: Methods and Outcomes (9 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). E Larsson collaborates with scholars based in Sweden, United States and Denmark. E Larsson's co-authors include Lars Klareskog, Rikard Holmdahl, Hans Wigzell, Kristofer Rubin, Gunnar Tufveson, Bengt Fellström, Mikael Andersson, L Jansson, B Fellström and Å. MÜSSENER and has published in prestigious journals such as JAMA, Annals of the Rheumatic Diseases and European Spine Journal.

In The Last Decade

E Larsson

41 papers receiving 944 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Larsson Sweden 15 339 291 287 280 215 45 1000
J J Weening Netherlands 17 351 1.0× 113 0.4× 178 0.6× 89 0.3× 121 0.6× 34 1.1k
Bonnie Mitchell United States 14 223 0.7× 213 0.7× 46 0.2× 137 0.5× 86 0.4× 28 804
A Fukatsu Japan 20 324 1.0× 205 0.7× 61 0.2× 62 0.2× 271 1.3× 41 1.1k
J. M. Gokel Germany 16 194 0.6× 110 0.4× 23 0.1× 145 0.5× 198 0.9× 36 787
N. Gunnar Westberg United States 14 226 0.7× 245 0.8× 81 0.3× 103 0.4× 67 0.3× 21 944
Beate M. Rüger Austria 16 318 0.9× 147 0.5× 89 0.3× 47 0.2× 233 1.1× 28 970
Sunao Maki Japan 13 141 0.4× 82 0.3× 83 0.3× 74 0.3× 96 0.4× 30 785
Diane Marshall United Kingdom 13 376 1.1× 141 0.5× 146 0.5× 43 0.2× 54 0.3× 15 765
Wayne W. Hancock United States 9 263 0.8× 49 0.2× 57 0.2× 33 0.1× 526 2.4× 9 883
Georg Stummvoll Austria 17 544 1.6× 286 1.0× 23 0.1× 82 0.3× 85 0.4× 32 944

Countries citing papers authored by E Larsson

Since Specialization
Citations

This map shows the geographic impact of E Larsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Larsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Larsson more than expected).

Fields of papers citing papers by E Larsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Larsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Larsson. The network helps show where E Larsson may publish in the future.

Co-authorship network of co-authors of E Larsson

This figure shows the co-authorship network connecting the top 25 collaborators of E Larsson. A scholar is included among the top collaborators of E Larsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Larsson. E Larsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Edwards, C J, et al.. (2020). PMS40 Starting Treatment with Baricitinib: Characteristics of Patients and Status at First Follow-up in the BSRBR-RA Registry. Value in Health. 23. S599–S600. 1 indexed citations
2.
Mease, Philip J., Désirée van der Heijde, Christopher T. Ritchlin, et al.. (2016). The efficacy and safety of ixekizumab, adalimumab, and placebo in patients with psoriatic arthritis naive to biological disease-modifying anti-rheumatic drugs : a double-blind phase 3 study. Scandinavian Journal of Rheumatology. 45. 31–33.
3.
Østergaard, Mikkel, Karin Franck‐Larsson, Marjatta Leirisalo‐Repo, et al.. (2014). In rheumatoid arthritis patients with stable low disease activity on etanercept plus methotrexate, continuation of etanercept is clinically and radiographically superior to discontinuation: results from a randomized, double-blind clinical trial. 43. 30–31.
4.
Tengstrand, Birgitta, E Larsson, Lars Klareskog, & Ingiäld Hafström. (2007). Randomized withdrawal of long‐term prednisolone treatment in rheumatoid arthritis: effects on inflammation and bone mineral density. Scandinavian Journal of Rheumatology. 36(5). 351–358. 23 indexed citations
5.
Larsson, E, et al.. (2005). CNI-1493, an inhibitor of proinflammatory cytokines, retards cartilage destruction in rats with collagen induced arthritis. Annals of the Rheumatic Diseases. 64(3). 494–496. 8 indexed citations
6.
Larsson, E. (2004). Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP. British journal of rheumatology. 43(4). 428–434. 62 indexed citations
7.
8.
Larsson, E, S. Aaro, & Birgitta Öberg. (1999). Activities and functional assessment 1 year after spinal fusion for paralytic scoliosis. European Spine Journal. 8(2). 100–109. 26 indexed citations
9.
Larsson, E, et al.. (1998). Preoperative evaluation of activity and function in patients with paralytic scoliosis. European Spine Journal. 7(4). 294–301. 7 indexed citations
10.
Larsson, E. (1997). Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis. British journal of rheumatology. 36(12). 1258–1261. 32 indexed citations
11.
Dimény, Emöke, B Fellström, E Larsson, Gunnar Tufveson, & Hans Lithell. (1992). Lipoprotein abnormalities in renal transplant recipients with chronic vascular rejection.. PubMed. 24(1). 366–366. 3 indexed citations
12.
Gannedahl, G, et al.. (1990). Characteristics of Mouse to Rat Xenograft Heart Transplantation. European Surgical Research. 22(4). 206–212. 20 indexed citations
13.
Fellström, Bengt, E Larsson, & Gunnar Tufveson. (1989). Strategies in chronic rejection of transplanted organs: a current view on pathogenesis, diagnosis, and treatment.. PubMed. 21(1 Pt 2). 1435–9. 34 indexed citations
14.
Claesson, Kerstin, L. Mjörnstedt, Lars Klareskog, et al.. (1988). Morphology of Rat Cardiac Allografts with Permanent Survival Induced by Antithymocyte Globulin. Scandinavian Journal of Immunology. 27(2). 171–179. 6 indexed citations
15.
Wahlberg, J, Torbjörn Andersson, C. Busch, et al.. (1988). The biopty biopsy technique: a major advance in the monitoring of renal transplant recipients.. PubMed. 20(3). 419–20. 17 indexed citations
16.
Larsson, E, et al.. (1987). Rapid immunodiagnosis of kidney rejection by using activation markers on kidney tubular cells and infiltrating T subset cells.. PubMed. 19(5). 3570–1. 1 indexed citations
17.
Wallander, Johan, Göran Läckgren, Erik Sandström, E Larsson, & Gunnar Tufveson. (1987). Small bowel transplantation in the rat: a new technique.. PubMed. 19(5). 4387–8. 4 indexed citations
18.
Lindgren, P. G., L Frödin, E Larsson, Gunnar Tufveson, & J Wahlberg. (1986). A NEW NEEDLE DEVICE FOR RENAL TRANSPLANT BIOPSY. 18. 98–103. 8 indexed citations
19.
Almgren, B, I Eriksson, A. Hemmingsson, et al.. (1978). Abdominal aortic aneurysm in homocystinuria.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 144(7-8). 545–8. 8 indexed citations
20.
Larsson, E & Per Westermark. (1978). Chronic hypertrophic vulvitis--a condition with similarities to cheilitis granulomatosa (Melkersson-Rosenthal syndrome). Acta Dermato Venereologica. 58(1). 92–93. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J J Weening Breakdown of academic impact, for papers by Bonnie Mitchell Breakdown of academic impact, for papers by A Fukatsu Breakdown of academic impact, for papers by J. M. Gokel Breakdown of academic impact, for papers by N. Gunnar Westberg Breakdown of academic impact, for papers by Beate M. Rüger Breakdown of academic impact, for papers by Sunao Maki Breakdown of academic impact, for papers by Diane Marshall Breakdown of academic impact, for papers by Wayne W. Hancock Breakdown of academic impact, for papers by Georg Stummvoll
Rankless by CCL
2026